Details for Patent: 4,322,438
✉ Email this page to a colleague
Summary for Patent: 4,322,438
Title: | Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne |
Abstract: | In a method of alleviating nodulocystic and conglobate acne in humans by the oral administration of 13-cis-retinoic acid, the improvement comprising: administering the 13-cis-retinoic acid in a high dosage of from 1.0 to 2.0 mg/kg/day for from 2 to 4 weeks; and reducing the amount of 13-cis-retinoic acid to a low dosage of from 0.25 to 0.5 mg/kg/day for a period of from 12 to 14 weeks, so that the total treatment period is about 16 weeks. |
Inventor(s): | Peck; Gary L. (Silver Spring, MD) |
Assignee: | United States of America (Washington, DC) |
Application Number: | 06/175,594 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 4,322,438
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |